Cargando…
Rethinking intercurrent events in defining estimands for tuberculosis trials
BACKGROUND/AIMS: Tuberculosis remains one of the leading causes of death from an infectious disease globally. Both choices of outcome definitions and approaches to handling events happening post-randomisation can change the treatment effect being estimated, but these are often inconsistently describ...
Autores principales: | Pham, Tra My, Tweed, Conor D, Carpenter, James R, Kahan, Brennan C, Nunn, Andrew J, Crook, Angela M, Esmail, Hanif, Goodall, Ruth, Phillips, Patrick PJ, White, Ian R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523802/ https://www.ncbi.nlm.nih.gov/pubmed/35850542 http://dx.doi.org/10.1177/17407745221103853 |
Ejemplares similares
-
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
por: Kahan, Brennan C., et al.
Publicado: (2020) -
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023) -
Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022) -
Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022) -
Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)